Evidence map›Paper›PMID 40232508›Full record

ArticleRheumatology international2025

Discounting seems the most toxic dimension of invalidation in fibromyalgia: a cross-sectional analysis.

Heidi Willemse, Johanna E Vriezekolk, Rinie Geenen

Abstract read
In one paragraph

Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Heidi WillemseDepartment of Psychology, Utrecht University, P.O. Box 80140, Utrecht, 3508 TC, The Netherlands. h.m.a.willemse@uu.nl.ORCID http://orcid.org/0000-0002-8281-167X
Johanna E VriezekolkDepartment of Research, Sint Maartenskliniek, P.O. Box 9011, Nijmegen, 6500 GM, The Netherlands.ORCID http://orcid.org/0000-0003-4783-8663
Rinie GeenenDepartment of Psychology, Utrecht University, P.O. Box 80140, Utrecht, 3508 TC, The Netherlands.ORCID http://orcid.org/0000-0002-6615-6708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invalidation, both discounting (overt negative social responses) and lack of understanding (absence of positive social responses), is a common problem in fibromyalgia. The 'Fibromyalgia Imbalance of Threat and Soothing Systems' (FITSS) model indicates that different neuropsychological processes may underlie these two components of invalidation. Guided by this model, the aim of the current study was to clarify the differentiation between these two components of invalidation by examining their association with fibromyalgia severity, anxiety, and depression. This cross-sectional study included the Illness Invalidation Inventory (3*I), the Fibromyalgia Impact Questionnaire (FIQ), and the Hospital and Depression Scale (HADS). Demographics of the 280 respondents with fibromyalgia were: mean age 42.6 ± 11.8 yrs., 95% female, mean FIQ score 59.1 ± 15,5, possible or probable cases of anxiety and depression, 49% and 42%, respectively. Regression analyses revealed that discounting was associated with severity of fibromyalgia (t = 4.10, β = 0.34, p <.001), anxiety (t = 3.50, β = 0.29, p <.001) and depression (t = 3.64, β = 0.30, p <.001) symptoms. Neither lack of understanding (-1.62 ≤ t ≤.10, -0.13 ≤ β ≤ 0.01, p ≥ 0.11) nor the interaction of discounting and lack of understanding (-0.19 ≤ t ≤ 1.10, -0.01 ≤ β ≤ 0.07, p ≥ 0.27) was related to any of the outcome variables. The total model accounted for 8.8%, 5.3%, and 8.3% (adjusted R

Indexed as

AnxietyDepressionFibromyalgiaAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSeverity of Illness IndexSurveys and QuestionnairesAnxietyDepressionFibromyalgiaInvalidationPhysical healthSocial rejectionSurveys and questionnaires

Identifiers

PMID40232508
PMCPMC12000205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.